Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection

Medicinal Research Reviews

Volumn 20, Issue 5, 2000, Pages 323-349

  De Clercq, Erik ^a  

^a REGA INSTITUTE FOR MEDICAL RESEARCH   (Belgium)

Author keywords

Anti HIV therapy; Antiviral agents; HIV (human immunodeficiency virus); Natural products

Indexed keywords

13 HYDROXYINGENOL 3 (2,3 DIMETHYLBUTANOATE) 13 DODECANOIC ACID; 4 (8 BETULINOYLAMINOOCTANOYLAMINO) 3 HYDROXY 6 METHYLHEPTANOIC ACID; AVAROL; AVARONE DERIVATIVE; BAICALIN; BETULIC ACID; BMY 29303; BMY 29304; CYANOVIRIN N; DEXTRAN SULFATE; DIHYDROBETULINIC ACID; EPICATECHIN; EPICATECHIN 3 O GALLATE; EPICATECHIN GALLATE; EPIGALLOCATECHIN GALLATE; FLAVANOID; FR 901724; GALACTAN; GLYCYRRHIZIC ACID; HEPARIN; INGENOL DERIVATIVE; LECTIN; MALLOTOJAPONIN; NATURAL PRODUCT; NP 06; PENTOSAN POLYSULFATE; PHLOROGLUCINOL DERIVATIVE; PLATANIC ACID; POLYSACCHARIDE SULFATE; PSYCHOTRINE; RD 4 2138; RP 71955; SIAMYCIN I; SIAMYCIN II; TJN 151; UNCLASSIFIED DRUG; UNINDEXED DRUG; XYLOMANNAN;

ALGA; BACTERIUM; DRUG MECHANISM; DRUG SPECIFICITY; DRUG STRUCTURE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 2; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IC 50; PLANT; REVIEW; SPONGE (PORIFERA); STRUCTURE ACTIVITY RELATION;

AMINO ACID SEQUENCE; ANTI-HIV AGENTS; BIOLOGICAL PRODUCTS; HIV INFECTIONS; HUMANS; MOLECULAR SEQUENCE DATA; MOLECULAR STRUCTURE;

EID: 0033850714     PISSN: 01986325     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-1128(200009)20:5<323::AID-MED1>3.0.CO;2-A     Document Type: Review

References (90)

1. Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection
2. Discovery of cyanovirin-N, a novel human immunodeficiency virus-inactivating protein that binds viral surface envelope glycoprotein gp120: Potential applications to microbicide development
3. Sulfated polysaccharides extracted from sea algae as potential antiviral drugs
4. Activity of a sulfated polysaccharide extracted from the red seaweed Aghardhiella tenera against human immunodeficiency virus and other enveloped viruses
5. Antiviral activity of a sulphated polysaccharide from the red seaweed Nothogenia fastigiata
6. Antiviral and anticoagulant activity of polysaccharides from marine brown algae
7. Antiviral activity of a sulphated polysaccharide extracted from the marine Pseudomonas and marine plant Dinoflagellata against human immunodeficiency viruses and other enveloped viruses
8. Novel sulfated polysaccharides: Dissociation of anti-human immunodeficiency virus activity from antithrombin activity
9. Sulfated polysaccharides are potent and selective inhibitors of various enveloped viruses, including herpes simplex virus, cytomegalovirus, vesicular stomatitis virus, and human immunodeficiency virus
10. Sulfated polysaccharides as potent inhibitors of HIV-induced syncytium formation: A new strategy towards AIDS chemotherapy
11. Differential inhibitory effects of sulfated polysaccharides and polymers on the replication of various myxoviruses and retroviruses, depending on the composition of the target amino acid sequences of the viral envelope glycoproteins
12. Antiviral portrait series: 4. Polysulfates as inhibitors of HIV and other enveloped viruses
13. Mechanism of selective inhibition of human immunodeficiency virus by ingenol triacetate
14. Ingenol derivatives are highly potent and selective inhibitors of HIV replication in vitro
15. Upregulation of HIV-1 replication in chronically infected cells by ingenol derivatives
16. Inhibition of HIV infection by flavanoids
17. Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases
18. Inhibitory effect of glycyrrhizin on the in vitro infectivity and cytopathic activity of the human immunodeficiency virus [HIV (HTLV-III/LAV)]
19. Mechanism of inhibitory effect of glycyrrhizin on replication of human immunodeficiency virus (HIV)
20. α-(1-3)- and α-(1-6)-D-mannose-specific plant lectins are markedly inhibitory to human immunodeficiency virus and cytomegalovirus infections in vitro
21. The mannose-specific plant lectins form Cymbidium hybrid and Epipactis helleborine and the (N-acetylglucosamine)(n)-specific plant lectin from Urtica dioica are potent and selective inhibitors of human immunodeficiency virus and cytomegalovirus replication in vitro
22. Isolation of RP 71955, a new anti-HIV-1 peptide secondary metabolite
23. Solution structure of RP 71955, a new 21 amino acid tricyclic peptide active against HIV-1 virus
24. High-resolution solution structure of siamycin II: Novel amphipathic character of a 21-residue peptide that inhibits HIV fusion
25. NP-06: A novel anti-human immunodeficiency virus polypeptide produced by a Streptomyces species
26. FR901724, a novel anti-human immunodeficiency virus (HIV) peptide produced by Streptomyces, shows synergistic antiviral activities with HIV protease inhibitor and 2',3'-dideoxynucleosides
27. Characterization of siamycin I, a human immunodeficiency virus fusion inhibitor
28. Anti-AIDS agents, 11. Betulinic acid and platanic acid as anti-HIV principles from Syzigium claviflorum, and the anti-HIV activity of structurally related triterpenoids
29. Betulinic acid and dihydrobetulinic acid derivatives as potent anti-HIV agents
30. Triterpene derivatives that block entry of human immunodeficiency virus type 1 into cells
31. Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): A possible inhibitor of virus-cell fusion
32. 7]-polyphemusin II)
33. Structure-activity relationships of an anti-HIV peptide, T22
34. A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection
35. 7]-polyphemusin II)
36. T134, a small-molecule CXCR4 inhibitor, has no cross-drug resistance with AMD3100, a CXCR4 antagonist with a different structure
37. Baicalin, an inhibitor of HIV-1 production in vitro
38. The inhibition of human immunodeficiency virus type 1 reverse transcriptase by avarol and avarone derivatives
39. Psychotrine and its O-methyl ether are selective inhibitors of human immunodeficiency virus-1 reverse transcriptase
40. Inhibition of HIV-reverse transcriptase activity by some phloroglucinol derivatives
41. The calanolides, a novel HIV-inhibitory class of coumarin derivatives from the tropical rainforest tree, Calophyllum lanigerum
42. The inophyllums, novel inhibitors of HIV-1 reverse transcriptase isolated from the Malaysian tree, Calophyllum inophyllum Linn
43. Structural analogues of the calanolide anti-HIV agents. Modification of the trans-10,11-dimethyldihydropyran-12-ol ring (ring C)
44. Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide
45. Illimaquinone, a selective inhibitor of the RNase H activity of human immunodeficiency virus type 1 reverse transcriptase
46. Inhibition of human immunodeficiency virus type-1 integrase by curcumin
47. Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: Inhibition of the core catalytic domain of human immunodeficiency virus integrase
48. Inhibitors of HIV-1 replication that inhibit HIV integrase
49. Curcumin analogs with altered potencies against HIV-1 integrase as probes for biochemical mechanisms of drug action
50. Dicaffeoylquinic and dicaffeoyltartaric acids are selective inhibitors of human immunodeficiency virus type 1 integrase
51. L-Chicoric acid, an inhibitor of human immunodeficiency virus type 1 (HIV-1) integrase, improves on the in vitro anti-HIV-1 effect of zidovudine plus a protease inhibitor (AG1350)
52. Resistance to the anti-human immunodeficiency virus type 1 compound L-chicoric acid results from a single mutation at amino acid 140 of integrase
53. Viral entry as the primary target for the anti-HIV activity of chicoric acid and its tetra-acetyl esters
54. Isolation and characterization of novel human immunodeficiency virus integrase inhibitors from fungal metabolites
55. Casein kinase II is a selective target of HIV-1 transcriptional inhibitors
56. Compounds that target novel cellular components involved in HIV-1 transcription
57. Inhibition of HIV activation in latently infected cells by flavonoid compounds
58. Antimicrobial peptides melittin and cecropin inhibit replication of human immunodeficiency virus 1 by suppressing viral gene expression
59. The structure of melittin. II. Interpretation of the structure
60. 1H-NMR study in methanol
61. Inhibition of human immunodeficiency virus type 1 replication in acutely and chronically infected cells by EM2487, a novel substance produced by a Streptomyces species
62. Isolation and DNA sequence of a gene encoding (α-trichosanthin, a type I ribosome-inactivating protein
63. MAP 30: A new inhibitor of HIV-1 infection and replication
64. A new class of anti-HIV agents: GAP31, DAPs 30 and 32
65. Solution structure of anti-HIV-1 and anti-tumor protein MAP30: Structural insights into its multiple functions
66. Inhibition of human immunodeficiency virus type 1 infectivity by a new amine bellenamine
67. Total synthesis of bellenamine and its isomers
68. Production of bellenamine and new metabolites in a synthetic medium
69. D-β-Lysylmethanediamine, a new biogenetic amine produced by a Streptomyces
70. Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: Aromatic polycyclic diones hypericin and pseudohypericin
71. Studies of the mechanisms of action of the antiretroviral agents hypericin and pseudohypericin
72. The synthesis and biological evaluation of hypericin analogs
73. Human immunodeficiency virus type 1 cDNA integration: New aromatic hydroxylated inhibitors and studies of the inhibition mechanism
74. Suppression of HIV-1 replication by propolis and its immunoregulatory effect
75. TXU (anti-CD7)-pokeweed antiviral protein as a potent inhibitor of human immunodeficiency virus
76. Inhibition of HIV-1 replication by an aqueous extract of Spirulina platensis (Arthrospira platensis)
77. Three new potent HIV-1 inhibitors from myxobacteria
78. 3-(5-Dimethylamino-1-naphthalenesulphonyl)-2-(3-pyridyl)thiazolid ine (YHI-1) selectively inhibits human immunodeficiency virus type 1
79. Inhibitory effect of glycosides like saponin from soybean on the infectivity of HIV in vitro
80. Anti-HIV michellamines from Ancistrocladus korupensis
81. Megalomicin inhibits HIV-1 replication and interferes with gp160 processing
82. SDZ NIM 811. Anti-HIV nonimmunosuppressive natural cyclosporin
83. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus (HIV) type 1: Interference with HIV protein-cyclophilin A interactions
84. Functional association of cyclophilin A with HIV-1 virions
85. Inhibition of HIV-1 replication by cyclosporine A or related compounds correlates with the ability to disrupt the gag-cyclophilin A interaction
86. The nonimmunosuppressive cyclosporin A analogue SDZ NIM 811 inhibits cyclophilin A incorporation into virions and virus replication in human immunodeficiency virus type 1-infected primary and growth-arrested T cells
87. Inhibition of human immunodeficiency virus type 1 replication by SDZ NIM 811, a nonimmunosuppressive cyclosporine analog
88. Mode of action of SDZ NIM 811, a nonimmunosuppressive cyclosporin A analog with activity against human immunodeficiency virus type 1 (HIV-1): Interference with early and late events in HIV-1 replication
89. Inhibition of human immunodeficiency virus replication by nonimmunosuppressive analogs of cyclosporin A